Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts
Value stocks are shares of companies that appear undervalued relative to their fundamentals. This means their stock price looks low compared with what the business earns, owns, or is expected to generate in the future. They often come from mature, financially stable companies with steady cash flow, consistent profits, and strong balance sheets.
Claim 70% Off TipRanks Premium
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential
Value stocks tend to have lower valuation ratios, such as low price‑to‑earnings (P/E) or price‑to‑book (P/B) ratios, suggesting the market may be underpricing the company.
Now, let’s check the three value stocks that analysts have spotlighted. Each offers more than 10% upside potential from current levels.
Here Are This Week’s Stocks
******PG&E ******PCG +0.28% ▲ – This is a major U.S. utility that provides electricity and natural gas to millions of customers. It has a Strong Buy analyst consensus rating and an average price target of $22.33, implying a 22.85% upside potential from the current levels. The company’s P/E of 13.06x reflects a 40.7% discount to the Utilities sector’s median of 22.04.
Recently, UBS Group upgraded PG&E stock to Buy with a new $23 target, citing improving wildfire policy and potential liability relief from upcoming legislation.
Jazz Pharmaceuticals JAZZ +0.29% ▲ – This biopharmaceutical company develops treatments for sleep disorders, cancer, and other serious medical conditions. Its average price target of $229.55 implies a 23.81% upside potential from the current levels. JAZZ stock has a Strong Buy consensus rating. Trading at a P/E of 12.74x, the company is valued 49.6% below the Healthcare sector’s median multiple of 25.26.
Last month, Jazz Pharmaceuticals posted Q4 revenue of about $1.2 billion, up roughly 10% year over year, with adjusted EPS of $6.64 beating expectations.
Royal Caribbean RCL -1.90% ▼ – This cruise operator is known for its mega-ships and premium vacation experiences across global destinations. It has a Strong Buy analyst consensus rating and an average price target of $375.14, implying a 34.9% upside potential from the current levels. With a P/E ratio of 17.69x, the stock is priced at a 12.1% discount to the Consumer Cyclical sector’s median of 20.13.
RCL stock has been sliding recently as rising geopolitical tensions in the Middle East weigh on travel demand and investor sentiment.
Disclaimer & DisclosureReport an Issue